Long Noncoding RNA UCA1 Overexpression Is Associated with Poor Prognosis in Digestive System Malignancies: A Meta-analysis

Abstract

Long noncoding RNA (lncRNA) urothelial carcinoma associated 1 (UCA1) has been reported to be highly expressed in many kinds of cancers. This meta-analysis summarized its potential prognostic value in digestive system malignancies. A meta-analysis was performed through a comprehensive search in PubMed, EMBASE, the Cochrane Library, Web of Science and Chinese National Knowledge Infrastructure (CNKI) for suitable articles on the prognostic impact of UCA1 in digestive system malignancies from inception to June 27, 2019. Pooled hazard ratios (HRs) with 95% confidence interval (95%CI) were calculated to summarize the effect. Sixteen studies were included in the study, with a total of 1504 patients. A significant association was observed between UCA1 abundance and poor overall survival (OS), and shorter disease-free survival (DFS) for patients with digestive system malignancies, with pooled HR of 2.07 (95%CI: 1.74–2.47), and of 2.50 (95%CI: 1.62–3.86). Subgroup analysis and sensitivity analysis suggested the reliability of our findings. It is suggested that UCA1 abundance may serve as a reliable predictive factor for poor prognosis in patients with digestive system malignancies.

Keywords

long noncoding RNAs / urothelial carcinoma associated 1 / prognosis / digestive system tumor / meta-analysis

References

[1] LinY, LiuZ, QiuY, et al.. Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: A systematic review and meta-analysis. Eur J Surg Oncol, 2018, 44(10): 1494-1503

[2] YinC, ZhouX, DangY, et al.. Potential Role of Circulating MiR-21 in the Diagnosis and Prognosis of Digestive System Cancer: A Systematic Review and Meta-Analysis. Medicine, 2015, 94(50): e2123

[3] MattickJS. The genetic signatures of noncoding RNAs. PLoS Genet, 2009, 5(4): e1000459

[4] QureshiIA, MehlerMF. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci, 2012, 13(8): 528-541

[5] SunY, WangZ, ZhouD. Long non-coding RNAs as potential biomarkers and therapeutic targets for gliomas. Med Hypotheses, 2013, 81(2): 319-321

[6] FurlanG, RougeulleC. Function and evolution of the long noncoding RNA circuitry orchestrating X-chromosome inactivation in mammals. Wiley Interdiscip Rev RNA, 2016, 7(5): 702-722

[7] ArunG, DiermeierS, AkermanM, et al.. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Gene Dev, 2016, 30(1): 34-51

[8] SchmitzSU, GroteP, HerrmannBG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci, 2016, 73(13): 2491-2509

[9] TaftRJ, PangKC, MercerTR, et al.. Non-coding RNAs: regulators of disease. J Pathol, 2010, 220(2): 126-139

[10] XueM, PangH, LiX, et al.. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci, 2016, 107(1): 18-27

[11] WangXS, ZhangZH, CaiJL, et al.. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res, 2006, 12(16): 4851-4858

[12] WangY, ChenW, YangC, et al.. Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol, 2012, 41(1): 276

[13] LiJY, MaX, ZhangCB. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol, 2014, 7(11): 7938-7944

[14] XueM, LiX, WuW, et al.. Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis. Oncol Rep, 2014, 31(5): 1993-2000

[15] NaXY, LiuZY, RenPP, et al.. Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway. Int J Clin Exp Med, 2015, 8(8): 12609-12616

[16] ShangC, GuoY, ZhangJ, et al.. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer. Cancer Chemother Pharmacol, 2016, 77(5): 1061-1067

[17] ZhengQ, WuF, DaiWY, et al.. Aberrant expression of UCA1 in gastric cancer and its clinical significance. Clin Transl Oncol, 2015, 17(8): 640-646

[18] NiB, YuX, GuoX, et al.. Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer. Int J Oncol, 2015, 47(4): 1329-1338

[19] TaoK, YangJ, HuY, et al.. Clinical significance of urothelial carcinoma associated 1 in colon cancer. Int J Clin Exp Med, 2015, 8(11): 21 854-21 860

[20] YangZ, LuY, XuQ, et al.. HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus. Dis Markers, 2015, 2015: 191029

[21] McShaneLM, AltmanDG, SauerbreiW, et al.. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat, 2006, 100(2): 229-235

[22] SauerbreiW, TaubeSE, McShaneLM, et al.. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration. J Natl Cancer Inst, 2018, 110(8): 803-811

[23] StangA. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605

[24] HigginsJP, ThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat Med, 2002, 21(11): 1539-1558

[25] HigginsJPT, ThompsonSG, DeeksJJ, et al.. Measuring inconsistency in meta-analyses. BMJ, 2003, 327(7414): 557-560

[26] Noyes J, Popay J, Pearson A, et al. Qualitative research and Cochrane reviews. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. John Wiley & Sons, Ltd, 2008.

[27] BeggCB, MazumdarM. Operating characteristics of a rank correlation test for publication bias. Biometrics, 1994, 50(4): 1088-1101

[28] EggerM. Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997, 315: 629-634

[29] DuvalS, TweedieR. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 2015, 56(2): 455-463

[30] BianZ, JinL, ZhangJ, et al.. LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep, 2016, 6: 23892

[31] ChenDT, Davis-YadleyAH, HuangPY, et al.. Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma. PloS One, 2015, 10(8): e0133562

[32] ChenP, WanD, ZhengD, et al.. Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer. Biomed Pharmacother, 2016, 83: 1220-1226

[33] FuXL, LiuDJ, YanTT, et al.. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma. Sci Rep, 2016, 6: 33535

[34] GaoJ, CaoR, MuH. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer. Int J Clin Exp Pathol, 2015, 8(10): 12936

[35] JiangH, ChenYT, FuXG. Tissue expression level of lncRNA UCA1 is a prognostic biomarker for colorectal cancer. Int J Clin Exp Pathol, 2016, 9(4): 4241-4246

[36] JiaoC, SongZ, ChenJ, et al.. lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer. Oncol Rep, 2016, 36(5): 2960

[37] WangF, YingHQ, HeBS, et al.. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget, 2015, 6(10): 7899-7917

[38] YuH, Ying-NanY, Heng-HengY, et al.. UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology, 2014, 46(5): 396-401

[39] MercerTR, DingerME, MattickJS. Long non-coding RNAs: insights into functions. Nature Rev Genet, 2009, 10(3): 155-159

[40] GibbEA, BrownCJ, WanLL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer, 2011, 10: 38

[41] PauliA, RinnJL, SchierAF. Non-coding RNAs as regulators of embryogenesis. Nature Rev Genet, 2011, 12(2): 136-149

[42] PrensnerJR, ChinnaiyanAM. The emergence of lncRNAs in cancer biology. Cancer Discov, 2011, 1(5): 391

[43] NobiliL, LionettiM, NeriA. Long non-coding RNAs in normal and malignant hematopoiesis. Oncotarget, 2016, 7(31): 50 666-50 681

[44] WangF, LiX, XieXJ, et al.. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett, 2008, 582(13): 1919-1927